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A BS TR AC T
BACKGROUND
Results from an observational study involving neonates suggested that high-frequency 
oscillatory ventilation (HFOV), as compared with conventional ventilation, was associ-
ated with superior small-airway function at follow-up. Data from randomized trials 
are needed to confirm this finding.
METHODS
We studied 319 adolescents who had been born before 29 weeks of gestation and 
had been enrolled in a multicenter, randomized trial that compared HFOV with 
conventional ventilation immediately after birth. The trial involved 797 neonates, of 
whom 592 survived to hospital discharge. We compared follow-up data from adoles-
cents who had been randomly assigned to HFOV with follow-up data from those who 
had been randomly assigned to conventional ventilation, with respect to lung func-
tion and respiratory health, health-related quality of life, and functional status, as 
assessed with the use of questionnaires completed when the participants were 11 
to 14 years of age. The primary outcome was forced expiratory flow at 75% of the 
expired vital capacity (FEF75).
RESULTS
The HFOV group had superior results on a test of small-airway function (z score for 
FEF75, −0.97 with HFOV vs. −1.19 with conventional therapy; adjusted difference, 
0.23 [95% confidence interval, 0.02 to 0.45]). There were significant differences in 
favor of HFOV in several other measures of respiratory function, including forced 
expiratory volume in 1 second, forced vital capacity, peak expiratory flow, diffusing 
capacity, and impulse-oscillometric findings. As compared with the conventional-
therapy group, the HFOV group had significantly higher ratings from teachers in 
three of eight school subjects assessed, but there were no other significant differences 
in functional outcomes.
CONCLUSIONS
In a randomized trial involving children who had been born extremely prematurely, 
those who had undergone HFOV, as compared with those who had received conven-
tional ventilation, had superior lung function at 11 to 14 years of age, with no evi-
dence of poorer functional outcomes. (Funded by the National Institute for Health 
Research Health Technology Assessment Programme and others.)
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A lthough survival rates have im-proved among infants with extremely low gestational age, the proportion of surviving 
infants with bronchopulmonary dysplasia remained 
unchanged between 1995 and 2006.1 Infants 
born extremely prematurely usually require respi-
ratory support. High-frequency oscillatory venti-
lation (HFOV) was proposed as a means of reduc-
ing the risk of bronchopulmonary dysplasia 
among neonates receiving ventilatory support. 
During HFOV, a constant pressure is applied to 
improve lung volume and oxygenation, while ven-
tilation is achieved with the use of very low tidal 
volumes.
In an early randomized trial comparing HFOV 
(with the use of a low-volume strategy) with 
conventional ventilation, a significantly higher 
proportion of infants in the HFOV group had 
grade 3 or 4 intraventricular hemorrhage and 
periventricular leukomalacia.2 Systematic reviews 
of randomized trials3,4 did not confirm these 
findings, but the adverse outcomes and benefi-
cial effects were inconsistent across the trials. 
One meta-analysis of randomized trials3 con-
cluded that the use of HFOV resulted in a sig-
nificant but modest reduction in the risk of 
bronchopulmonary dysplasia, but a meta-analysis 
of patient-level data4 did not show any advantage 
of HFOV over conventional ventilation, with re-
spect to short-term outcomes, including broncho-
pulmonary dysplasia.
Limited data are available on lung function at 
the time of follow-up of infants who had been 
enrolled in trials of HFOV. No significant differ-
ences with respect to measurements of pulmo-
nary mechanics were observed at 9 months of 
corrected age between infants who had under-
gone HFOV (with the use of a low-volume strat-
egy) and those who had undergone conventional 
ventilation in a randomized trial.5 Although small-
airway function appears to decline during infancy 
in prematurely born infants supported with con-
ventional ventilation,6 the results of an observa-
tional study of 36 infants born very prematurely 
suggested that this decline did not occur among 
infants initially supported by HFOV.7
The United Kingdom Oscillation Study (UKOS) 
was a multicenter, randomized trial, involving 
very premature infants, in which HFOV (with the 
use of a high-volume strategy) was compared 
with conventional ventilation, initiated within 
1 hour after birth, with respect to the risk of 
bronchopulmonary dysplasia or death.8 Exami-
nation of a subgroup of the infants at 1 year of 
corrected age revealed no significant differences 
in the results of lung-function tests,9 but tests 
of small-airway function were not assessed. 
The current study was designed to determine the 
long-term outcomes in children enrolled in the 
UKOS to test the hypothesis that the use of 
HFOV during the newborn period would be 
 associated with superior small-airway function 
at school age. We also assessed other respiratory 
and educational outcomes in these children.
ME THODS
STUDY DESIGN AND OVERSIGHT
In the UKOS, we recruited 797 infants, all born 
before 29 weeks of gestation, at 25 centers: 
22 centers in England, Scotland, and Wales and 
1 each in Ireland, Singapore, and Australia. The 
target group for the current study included all 
538 children from England, Scotland, Wales, 
and Ireland who had survived to hospital dis-
charge (Fig. 1).
We had kept in contact with the children in-
volved in the UKOS since the 2-year follow-up, send-
ing birthday cards and news updates. Families 
were invited to participate in the follow-up study 
that included children 11 to 14 years of age; in-
vitations were sent by mail; if there was no re-
sponse to the initial letter, attempts were made 
to contact the families by means of e-mail, tele-
phone calls, or both.
Children whose parents provided consent were 
asked to undergo comprehensive lung-function 
assessments (performed at King’s College Hos-
pi tal National Health Service Foundation Trust 
[KCH]). All the assessments were conducted by 
researchers who were unaware of the child’s as-
signed ventilation strategy. Children and parents 
were also asked to complete questionnaires re-
garding respiratory disorders, health-related qual-
ity of life, and functional status, and teachers 
were asked to complete questionnaires regarding 
the children’s academic achievement and behav-
ior (described below and in the Supplementary 
Appendix, available with the full text of this ar-
ticle at NEJM.org). Parents and their children who 
were unable to come to KCH completed the ques-
tionnaires only.
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The South West London National Research 
Ethics Service Committee approved the current 
study. Parents provided written informed con-
sent for their child to take part in the study; 
formal consent was not required from the child. 
All the children who underwent lung-function 
measurements assented to the measurements. 
The second and last authors vouch for the integ-
rity and completeness of the data and analyses 
reported and for the fidelity of the trial to the 
study protocol.
ASSESSMENTS
Respiratory Function
The primary outcome was small-airway function, 
as assessed by measurement of forced expiratory 
flow at 75% of the expired vital capacity (FEF75) 
with the use of a spirometer. All assessments 
were performed according to guidelines from the 
American Thoracic Society and the European Re-
spiratory Society. Airway function was also as-
sessed by means of spirometric measurement of 
the forced expiratory flow at 50% and 25% of ex-
pired vital capacity (FEF50 and FEF25, respectively), 
forced expiratory volume in 1 second (FEV1), and 
peak expiratory flow (PEF). Impulse oscillometry 
was used to assess respiratory-system resistance.10 
Inhomogeneity of ventilation distribution was 
assessed by means of a multiple-breath technique 
assessing the lung-clearance index (Innocor 
photoacoustic gas analyzer, Innovision).11,12 Lung 
volumes were assessed by means of measurements 
of functional residual capacity with the use of 
a helium-dilution technique (FRCHe) and forced 
vital capacity (FVC) by means of spirometry.
The following assessments of lung volumes 
were also undertaken: functional residual capac-
ity as assessed by means of plethysmography 
(FRCpleth) and plethysmographic assessments 
of total lung capacity and residual volume. Two 
measurements within 5% of each other were 
averaged to calculate the results.13-15 The diffus-
ing capacity of the lung for carbon monoxide 
(DLCO), alveolar volume, and gas transfer per 
unit volume were assessed with the use of the 
single-breath gas-transfer technique.16 All lung-
function results were expressed as the percent-
age predicted for height with the use of estab-
lished reference ranges17-19 and were converted 
into z scores as appropriate. The fraction of ex-
797 Patients in 23 centers in the United Kingdom and Ireland 
and 2 overseas centers underwent randomization
397 Were assigned to conventional
ventilation
292 Survived to hospital discharge
400 Were assigned to high-frequency
oscillatory ventilation
300 Survived to hospital discharge
140 Were lost to follow up
at age 11–14 yr
11 Died
28 Were at overseas center
4 Declined to participate
97 Could not be contacted
133 Were lost to follow up
at age 11–14 yr
4 Died
26 Were at overseas center
6 Declined to participate
2 Moved overseas
95 Could not be contacted
 159 Were included in follow-up and 
 analysis
123 Completed assessment and
questionnaire
  33 Completed questionnaire only
  3 Completed assessment only
160 Were included in follow-up and 
 analysis
133 Completed assessment and
questionnaire
  26 Completed questionnaire only
  1 Completed assessment only
Figure 1. Randomization, Follow-up, and Analysis Populations.
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haled nitric oxide (FeNO) was measured by means 
of a real-time method with the use of a comput-
erized system and visual display (HypAir FeNO, 
Medisoft Cardio-respiratory Instrumentation).
Other Assessments
Parents were asked about a family history of 
asthma (in parents or siblings). Atopy was assessed 
by means of skin-prick testing. The allergens tested 
were mixed-grass pollen, Dermatophagoides ptero­
nyssinus, D. farinae, cat dander, and dog dander.
Behavioral outcomes, health-related quality of 
life, and academic achievement were assessed 
by means of questionnaires; these included the 
Strengths and Difficulties Questionnaire (SDQ; 
completed separately by the child, the parents, 
and the teacher; total scores from the five sub-
scales range from 0 to 40, with higher scores in-
dicating a greater degree of difficulty), the Health 
Utilities Index Mark 3 (HUI3; completed sepa-
rately by the parents and the child; scores range 
from −0.36 to 1, with lower scores indicating 
more severe health problems), and the Teacher 
Academic Attainment Scale (completed by the 
teachers in mainstream schools; scores range 
from 1 to 5 for each school subject, with higher 
scores indicating better performance). A question-
naire regarding respiratory health, symptoms, 
medicine use, hospital admissions, and neuro-
logic illness was also completed by the parents. 
Parents were asked about the presence of smokers 
in the house, and a urine sample for the detec-
tion of cotinine was obtained from all the chil-
dren at the time of assessment.
STATISTICAL ANALYSIS
The study was analyzed as a two-group, parallel 
study in keeping with the original trial design. 
We calculated that with a follow-up sample of 
320 children, the study would have 90% power to 
show a difference in means of 0.36 SD for the 
FEF75 results and the other lung-function results, 
at the 5% significance level. 
For the main analysis of outcomes, includ-
ing the FEF75 z score (primary outcome), we used 
mixed models, with the mother or the pregnancy 
as the random effect to allow for clustering due 
to multiple births.20 Skewed lung-function FeNO 
outcome data were log-transformed. We adjusted 
for imbalances in baseline factors by including 
those factors as fixed effects in the models. In 
sensitivity analyses, each lung-function outcome 
was also adjusted for bronchopulmonary dyspla-
sia, pubertal stage, and cotinine level. The primary 
outcome, FEF75, and 19 secondary lung-function 
outcomes were prespecified. Initially, we did not 
adjust for multiple testing, but we then under-
took a sensitivity analysis using the Bonferroni 
adjustment. This provided a test of the compos-
ite hypothesis that the mean lung-function re-
sults would not differ between the two ventila-
tion groups, such that if any comparison had a 
P value of less than 0.05÷19 (i.e., <0.0026), the 
composite hypothesis would be rejected.21
In the case of children who were unable to 
complete all the lung-function tests, multiple 
imputation with the use of chained equations 
was used to impute missing data. Nine variables 
plus all lung-function variables were used to 
impute the data. Differences in means between 
two groups can be difficult to interpret clinically, 
so we calculated the equivalent group difference 
as the difference in the proportion of children in 
each group with an FEF75 value below the 10th 
percentile (z score less than −1.28). We used a 
statistical method that was based on the normal 
distribution that gives the same P value as a test 
of the equivalent differences in means.22 All sta-
tistical analyses were performed with the use of 
Stata software, version 12.1 (StataCorp).
R ESULT S
PARTICIPANT RECRUITMENT
Figure 1 shows the numbers of children enrolled, 
as well as the reasons for nonparticipation, among 
the 592 children at all the centers who survived 
to hospital discharge. A total of 319 children 
completed the study: 59 children completed the 
detailed questionnaires only, 4 completed the as-
sessment only, and 256 completed both the ques-
tionnaires and the assessment at KCH. No child 
had an adverse event during assessment. As com-
pared with children who were not recruited for 
the study, those who were recruited were more 
likely to have a mother who was white and who 
did not smoke during pregnancy and were less 
likely to live in a disadvantaged area (Table S1 in 
the Supplementary Appendix).
BASELINE AND FOLLOW-UP CHARACTERISTICS
As compared with children in the HFOV group, 
those in the conventional-ventilation group had 
had a higher mean weight and gestational age at 
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birth and were more likely to have received sur-
factant (Table 1, and Table S2 in the Supplemen-
tary Appendix). There were no significant be-
tween-group differences in the characteristics of 
the children when they were assessed at 11 to 14 
years of age (Table 1).
Table 1. Maternal, Neonatal, and Follow-up Characteristics, According to Ventilation Group.*
Characteristic
Conventional 
Ventilation
(N = 159)
HFOV
(N = 160) P Value
Maternal
Race — no./total no. (%)† 0.92
White 142/158 (90) 143/160 (89)
Black 11/158 (7) 10/160 (6)
Other 5/158 (3) 7/160 (4)
Smoking during pregnancy — no./total no. (%.) 31/146 (21) 38/146 (26) 0.34
Neonatal
Male sex — no. (%) 85 (53) 77 (48) 0.34
Birth weight — g 923±206 867±209 0.02
Birth-weight z score 0.52
Mean −0.55 −0.62
Range −2.94 to 1.73 −3.45 to 2.41
Gestational age at birth — wk 27.0±1.2 26.7±1.5 0.04
Multiple birth — no. (%) 39 (25) 37 (23) 0.77
Surfactant administered — no. (%) 158 (99) 152 (95) 0.04
Receipt of postnatal glucocorticoids — no./total no. (%) 36/157 (23) 48/157 (31) 0.13
Oxygen dependency at 36 wk of postmenstrual age — no. (%) 95 (60) 88 (55) 0.39
Follow-up at 11–14 yr of age
No. of participants with assessment 121 127
Age — yr 12.5±0.6 12.6±0.6 0.66
Weight — kg 0.53
Mean 44.4 44.9
Range 23.4 to 102 19.0 to 86.7
Height — cm 0.26
Mean 153 151
Range 129 to 173 124 to 172
Cotinine level‡— no./total no. (%) 0.84
Undetectable 85/106 (80) 92/115 (80)
Passive smoking 4/106 (4) 3/115 (3)
Likely active smoking 17/106 (16) 20/115 (17)
No. of parents who completed questionnaires 150 154
Report of smoker in the family — no./total no. (%)§ 44/149 (30) 51/152 (34) 0.45
Report of doctor-diagnosed asthma — no./total no. (%)§ 76/150 (51) 72/154 (47) 0.50
* Plus–minus values are means ±SD. HFOV denotes high-frequency oscillatory ventilation.
† Race was reported by the mother.
‡ A cotinine level of less than 10 ng per milliliter was defined as undetectable, a level of 10 to 15 ng per milliliter was con-
sidered to indicate passive smoking, and a level of more than 15 ng per milliliter was considered to indicate likely active 
smoking.
§ Reports refer to members of the child’s family living in the same home (e.g., mother, father, a partner, and siblings).
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LUNG-FUNCTION AND ALLERGY ASSESSMENT RESULTS
Our final follow-up sample comprised 319 chil-
dren, but only 248 underwent lung-function test-
ing; hence, the study was powered to detect a 
difference of 0.41 SD for the FEF75 results. The 
mean z score for the FEF75 was higher in the 
HFOV group than in the conventional-ventilation 
group (−0.97 vs. −1.19) (Table 2). This difference 
was significant in both the unadjusted model 
that allowed for multiple births and in the fully 
adjusted model. The two groups had similar dis-
tributions of FEF75 z scores, with the distribution 
shifted downward in the conventional-ventilation 
group (Fig. S1 in the Supplementary Appendix); 
the percentage of children with results below the 
10th percentile was 37% in the HFOV group, as 
compared with 47% in the conventional-ventilation 
group (P = 0.04).
There were significant differences between 
the ventilation groups — all favoring the HFOV 
group — with respect to the results of the fol-
lowing tests: FEF25, FEF50, FEV1, FEV1:FVC ratio, 
PEF, DLCO, vital capacity, and respiratory resis-
tance at 5 Hz (Table 2). When adjustment was 
made for multiple testing, the results were es-
sentially unchanged. The differences between 
the groups remained significant and materially 
unchanged in a model that was also adjusted for 
pubertal stage and cotinine levels (Table S4 in 
the Supplementary Appendix). Results were also 
similar when multiple imputation was used to 
address incomplete lung-function data (Table S5 
in the Supplementary Appendix). Post hoc calcu-
lation of the intercorrelations among all pairs of 
lung-function measurement results showed cor-
relations ranging from −0.01 to 0.92 (Table S6 in 
the Supplementary Appendix).
OTHER OUTCOMES
There were no significant differences between the 
ventilation groups with regard to reported respi-
ratory disorders during the previous 12 months or 
health problems as documented by the parent-
completed questionnaire (Table 3, and Table S7 
in the Supplementary Appendix). There were also 
no significant between-group differences in the 
results of the HUI3 or the SDQ (Table S8 in the 
Supplementary Appendix). When the SDQ scores 
were dichotomized, the only significant differ-
ence between the two groups was in children’s 
reporting of emotional symptoms, which was 
more frequent in the HFOV group than in the 
conventional-ventilation group (odds ratio, 2.50; 
95% confidence interval, 1.13 to 5.56) (Table S9 
in the Supplementary Appendix).
A questionnaire regarding academic achieve-
ment and special-education provision was com-
pleted by a teacher at each child’s school for 225 
of the 319 children. The HFOV group was rated 
significantly higher in three of eight school sub-
jects assessed: art and design, information tech-
nology, and design and technology. There were no 
significant differences between the two groups 
with regard to the percentages of children attend-
ing a mainstream school or requiring special 
education (Table 4, and Table S10 in the Sup ple-
mentary Appendix).
DISCUSSION
We found that among school children who had 
been born extremely prematurely, those who had 
been supported by HFOV during the neonatal pe-
riod had significantly, albeit modestly, better 
outcomes in tests of small-airway function than 
those who had been supported by conventional 
ventilation (between-group difference in mean 
FEF75, 0.23 SD). The children who had been ran-
domly assigned to HFOV also had superior out-
comes in tests of large-airway function, as as-
sessed by means of several volitional measures 
(FEV1, FEF50, and FEF25) and a nonvolitional test 
(impulse oscillometry), and they had better DLCO 
results than those assigned to conventional ven-
tilation, suggesting a greater functional lung-
surface area for gas exchange.
The differences in lung-function measures, 
although significant, were relatively small: approx-
imately 0.3 SD, on average. When we analyzed 
these data to assess the proportion of children 
with an FEF75 below the 10th percentile (for age, 
height, and sex), we observed a significantly higher 
percentage in the conventional-ventilation group 
(47%, vs. 37% in the HFOV group), a difference 
that is likely, in our opinion, to be of clinical 
importance. The relatively small mean effect size 
and the respiratory reserve in childhood may ex-
plain the absence of a significant increase in re-
spiratory disorders in the conventional-ventilation 
group, as documented by responses on the par-
ent-completed questionnaires to questions re-
garding symptom status and the need for medi-
cation. Nevertheless, the poorer lung function in 
the conventional-ventilation group than in the 
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HFOV group may have consequences over time 
— for example, by causing greater vulnerability 
to lung-function insults such as smoking.
A prior follow-up study involving 69 children 
at approximately 6 years of age who had been 
enrolled as neonates in another randomized trial 
of HFOV with the use of a lung-recruitment strat-
egy versus conventional ventilation23 also showed 
no significant between-group differences in the 
frequency of respiratory disorders but did show 
superior lung function in the HFOV group.24 The 
conventional-ventilation group had decreased PEF, 
increased residual volume, and greater maldistri-
bution of ventilation, as compared with the HFOV 
group.24
We planned that 320 children would undergo 
Table 2. Lung-Function and Allergy-Test Results, According to Ventilation Group.*
Result
No. of 
Participants 
with Result†
Conventional 
Ventilation
(N = 121)
HFOV
(N = 127)
Adjusted Difference 
(95% CI)‡ P Value
FEF z score
FEF75 248 −1.19±0.80 −0.97±0.95 0.23 (0.02 to 0.45) 0.04
FEF50 248 −1.37±0.85 −1.07±0.93 0.30 (0.09 to 0.52) 0.006
FEF25 248 −1.16±0.95 −0.84±0.90 0.29 (0.07 to 0.51) 0.01
FEF25–75 231 −1.58±1.05 −1.34±1.09 0.21 (−0.04 to 0.47) 0.10
FEV1 z score 248 −0.95±1.02 −0.60±1.08 0.35 (0.09 to 0.60) 0.008
FVC z score 248 −0.44±0.89 −0.29±1.05 0.13 (−0.10 to 0.37) 0.27
FEV1:FVC ratio z score 248 −1.75±1.78 −1.16±1.75 0.58 (0.16 to 0.99) 0.007
PEF — % of predicted 247 80.3±15.0 86.3±15.5 5.85 (2.21 to 9.49) 0.002
Gas transfer
DLCO z score 210 −1.10±0.92 −0.81±1.19 0.31 (0.04 to 0.58) 0.02
VA (liters) 210 3.44±0.66 3.40±0.59 −0.05 (−0.20 to 0.09) 0.48
DLCO/VA (mmol/min/kPa/liter) 210 1.73±0.20 1.76±0.21 0.04 (−0.01 to 0.09) 0.11
Residual volume z score 211 0.46±1.19 0.31±1.35 −0.09 (−0.42 to 0.24) 0.60
Total lung capacity z score 213 0.20±1.00 0.36±1.13 0.16 (−0.12 to 0.43) 0.26
FRC z score
FRCpleth 218 −0.07±1.26 −0.11±1.28 −0.08 (−0.41 to 0.25) 0.63
FRCHe 229 −0.62±1.10 −0.75±1.05 −0.18 (−0.44 to 0.08) 0.19
Vital capacity z score 213 −0.50±0.88 −0.17±1.09 0.31 (0.05 to 0.57) 0.02
Respiratory resistance — %  
of predicted
At 5 Hz 237 99.6±23.2 92.5±20.9 −7.1 (−12.5 to −1.8) 0.009
At 20 Hz 237 95.5±23.8 90.2±22.1 −5.2 (−10.7 to 0.2) 0.06
* Plus–minus values are means ±SD. CI denotes confidence interval, DLCO diffusing capacity of the lung for carbon mon-
oxide, FEF forced expiratory flow (with FEF25, FEF50, and FEF75 indicating 25%, 50%, and 75%, respectively, of the ex-
pired vital capacity), FRCHe functional residual capacity with the use of a helium-dilution technique, FRCpleth functional 
residual capacity as assessed by means of plethysmography, FVC forced vital capacity, PEF peak expiratory flow, and VA 
alveolar volume.
† Lung-function values were missing for the following measures: FEF25–75 for 10 participants in the conventional-ventila-
tion group and 7 in the HFOV group, PEF for 1 in the conventional-ventilation group, DLCO and VA for 14 in the con-
ventional-ventilation group and 24 in the HFOV group, residual volume for 15 and 22, respectively, total lung capacity 
for 14 and 21, respectively, FRCpleth for 14 and 16, respectively, FRCHe for 8 and 11, respectively, vital capacity for 14 
and 21, respectively, and respiratory resistance at 5 Hz and at 20 Hz for 5 and 6, respectively.
‡ The differences in z scores are presented as HFOV group − conventional-ventilation group, with adjustment for birth 
weight, gestational age, and whether surfactant had been administered. The differences in percentages are presented 
as mean percentage points (HFOV group – conventional-ventilation group), with adjustment for birth weight, gesta-
tional age, and whether surfactant had been administered before birth.
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full assessment. Our total recruitment was on 
target (319 children), and most children com-
pleted questionnaires; however, only 248 chil-
dren underwent full assessment, including lung-
function measurements. Nevertheless, our study 
was adequately powered to detect a small differ-
ence in the means of the lung-function results 
with the use of a mixed-effects model.
We compared the results of the lung-function 
testing with reference ranges that did not cor-
rect for ethnic group. Reference ranges that ap-
ply to multiple ethnic groups are now available, 
but for spirometric results only.25 Our study as-
sessed a wide range of lung-function tests, and 
we considered it to be important to use the same 
reference ranges for as many as possible of 
our lung-function measurements for consistency. 
Furthermore, 90% of the participants in our 
study population were white, rendering the need 
for adjustment for ethnic group less important.
We were concerned that any respiratory ben-
efit associated with use of HFOV might have 
been associated with adverse neurodevelopmen-
tal outcomes, because, in some trials, HFOV has 
been associated with an increased risk of neona-
tal brain injury.2,26 There were no significant 
differences between our study groups with re-
gard to health-related quality of life or behavior, 
other than a higher proportion of children in the 
HFOV group reporting emotional symptoms. 
Multiple comparisons were performed, however, 
and this finding may be explained by chance. In 
contrast, the HFOV group had significantly 
higher mean ratings by teachers with respect to 
art and design, information technology, and 
design and technology, suggesting the possi-
bility that visuospatial skills were better in 
that group than in the conventional-ventilation 
group. A limitation of our study is the absence 
of formal testing of neurocognitive function, but 
our findings provide no evidence of worse func-
tional outcomes in the HFOV group than in the 
conventional-ventilation group.
In the original trial,8 we had specified initial 
ventilator settings (inflation rate and duration) 
for the conventional-ventilation group; further 
Table 3. Respiratory and Other Disorders in the Previous 12 Months, as Documented in the Parent Questionnaire.
Respiratory Disorder
Conventional 
Ventilation
(N = 150)
HFOV
(N = 154)
Adjusted  
Odds Ratio
(95% CI)* P Value
Wheezing — no. (%) 22 (15) 23 (15) 1.01 (0.53–1.90) 0.98
Frequency of wheezing — no./total no. (%)† 0.76
Daily 1/22 (5) 5/22 (23)
Weekly 1/22 (5) 2/22 (9)
Monthly 4/22 (18) 4/22 (18)
Less than monthly 16/22 (73) 11/22 (50)
Medication for chest problems — no./total no. (%)‡§
Antibiotic agent 22/150 (15) 18/154 (12) 0.69 (0.34–1.43) 0.32
Other medicine 24/150 (16) 23/152 (15) 0.94 (0.50–1.77) 0.85
Hospital admission — no./total no. (%)¶ 15/150 (10) 18/152 (12) 0.95 (0.45–1.99) 0.89
Chest problem — no.§ 4 0
Surgery — no. 8 13
Other — no. 8 5
Cerebral palsy — no.‖ 13 18 0.38
* The odds ratio was adjusted for birth weight, gestational age, and whether surfactant had been administered.
† Data were missing for one child in the HFOV group.
‡ Analyses were based on yes versus no responses.
§ Chest problems were defined as respiratory infection and asthma.
¶ Patients may have been admitted to the hospital for multiple reasons.
‖ The analysis assumed that participants who did not respond did not have the particular health problem. Estimates 
were unadjusted, owing to small numbers.
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adjustments to bring blood gases into the target 
ranges were made at the discretion of the indi-
vidual clinician. This design represents actual 
practice in many newborn intensive care units.27
New triggered modes and volume-targeted 
ventilation are now being used, in addition to 
other conventional-ventilation modes that were 
used in the UKOS. In a systematic review, 
 volume-targeted ventilation was associated with 
a reduction in the combined outcome of death 
or bronchopulmonary dysplasia,28 but there are 
no data to inform whether this strategy or the 
new triggered modes will influence long-term 
pulmonary outcomes. The volumes used during 
HFOV are less than half those used during 
 volume-targeted ventilation29; we speculate that 
this may be the mechanism for the protective 
effect of HFOV on small-airway function.
In conclusion, our results suggest that the 
use of HFOV, as compared with conventional 
ventilation, immediately after birth in very pre-
maturely born infants was associated with 
modest improvements in lung function and with 
no evidence of a poorer functional outcome 
when the children were 11 to 14 years of age.
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Table 4. Educational-Attainment Scores and Educational Provision, According to Ventilation Group.*
Variable
No. of  
Participants 
with Result†
Conventional 
Ventilation 
(N = 109)
HFOV
(N = 116)
Adjusted Difference
(95% CI) P Value
Area of study — score‡
English or literacy 219 2.81±1.04 2.92±0.91 0.12 (−0.13 to 0.37) 0.35
Mathematics 218 2.76±1.03 2.76±1.01 0.04 (−0.22 to 0.31) 0.75
Art and design 208 2.76±0.89 3.00±0.79 0.31 (0.09 to 0.54) 0.006
Geography 206 2.79±0.91 2.88±0.77 0.11 (−0.09 to 0.32) 0.27
History 205 2.81±0.89 2.92±0.84 0.18 (−0.06 to 0.41) 0.14
Information technology 204 2.82±0.80 3.00±0.78 0.24 (0.03 to 0.45) 0.02
Science 215 2.83±0.99 2.96±0.83 0.19 (−0.05 to 0.43) 0.12
Design and technology 197 2.80±0.88 3.04±0.75 0.27 (0.05 to 0.49) 0.02
Average of all subjects 221 2.79±0.79 2.93±0.70 0.16 (−0.02 to 0.35) 0.08
Educational provision — no./total  
no. (%)
Mainstream school 301 88/148 (59) 85/153 (56) 0.90 (0.54 to 1.49) 0.69
Special-education needs§ 224 57/108 (53) 60/116 (52) 0.94 (0.54 to 1.62) 0.83
* Plus–minus values are means ±SD. Data for scores in areas of study and for special-education needs were obtained 
from teacher questionnaires (for 225 of 319 children), and data on mainstream school were obtained from parent ques-
tionnaires (for 305 of 319 children).
† School-attainment scores were missing or not applicable for the following subjects: English or literacy for 2 children in 
the conventional-ventilation group and 4 in the HFOV group, mathematics for 4 and 3, respectively, art and design for 
9 and 8, respectively, geography for 10 and 9, respectively, history for 11 and 9, respectively, information technology for 
12 and 9, respectively, science for 6 and 4, respectively, design and technology for 17 and 11, respectively, and the aver-
age of all subjects for 1 and 3, respectively. Mainstream-school data were missing for 2 children in the conventional-
therapy group and 2 in the HFOV group. Special education data were missing for 1 child in the conventional-therapy 
group.
‡ Teachers of children in mainstream schools rated each child’s performance in eight school subjects, according to the 
following scores: 1 indicated very below average, 2 below average, 3 average, 4 above average, and 5 very above aver-
age. The average subject score is the mean of all available subject scores.
§ Results were based on the teacher’s yes-or-no response to the question, “Does this child have any special-education needs?”
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